Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) — Form 10-Q: Quarterly report

10-QKYTXFiled Nov 12, 2026, 3:04 AM ET· Period Sep 30, 2026

About this filing

Kyverna Therapeutics, Inc. (KYTX) filed Form 10-Q (quarterly report) with the SEC on Nov 12, 2026. A 10-Q is the company’s quarterly financial report.

View original filing on SEC.gov

Key facts

Document: 10-Q

More KYTX filings

8-K
Current report
Filed Nov 12, 2026
SC 13G
Ownership over 5% (passive)
Filed Oct 19, 2026
8-K
Current report
Filed Sep 24, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Aug 14, 2026
10-Q
Quarterly report
Filed Aug 11, 2026
8-K
Current report
Filed Aug 11, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.